253 related articles for article (PubMed ID: 19155748)
1. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.
Gehrman PR; Connor DJ; Martin JL; Shochat T; Corey-Bloom J; Ancoli-Israel S
Am J Geriatr Psychiatry; 2009 Feb; 17(2):166-9. PubMed ID: 19155748
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.
Singer C; Tractenberg RE; Kaye J; Schafer K; Gamst A; Grundman M; Thomas R; Thal LJ;
Sleep; 2003 Nov; 26(7):893-901. PubMed ID: 14655926
[TBL] [Abstract][Full Text] [Related]
3. Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial.
Bourne RS; Mills GH; Minelli C
Crit Care; 2008; 12(2):R52. PubMed ID: 18423009
[TBL] [Abstract][Full Text] [Related]
4. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial.
Riemersma-van der Lek RF; Swaab DF; Twisk J; Hol EM; Hoogendijk WJ; Van Someren EJ
JAMA; 2008 Jun; 299(22):2642-55. PubMed ID: 18544724
[TBL] [Abstract][Full Text] [Related]
5. Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.
Tariot PN; Raman R; Jakimovich L; Schneider L; Porsteinsson A; Thomas R; Mintzer J; Brenner R; Schafer K; Thal L; ;
Am J Geriatr Psychiatry; 2005 Nov; 13(11):942-9. PubMed ID: 16286437
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review.
de Jonghe A; Korevaar JC; van Munster BC; de Rooij SE
Int J Geriatr Psychiatry; 2010 Dec; 25(12):1201-8. PubMed ID: 21086534
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW;
PLoS Med; 2018 Jun; 15(6):e1002587. PubMed ID: 29912983
[TBL] [Abstract][Full Text] [Related]
9. Effect of melatonin in selected populations of sleep-disturbed patients.
Brusco LI; Fainstein I; Márquez M; Cardinali DP
Biol Signals Recept; 1999; 8(1-2):126-31. PubMed ID: 10085474
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials.
Grossberg GT; Kohegyi E; Mergel V; Josiassen MK; Meulien D; Hobart M; Slomkowski M; Baker RA; McQuade RD; Cummings JL
Am J Geriatr Psychiatry; 2020 Apr; 28(4):383-400. PubMed ID: 31708380
[TBL] [Abstract][Full Text] [Related]
11. Effects of a Tailored Lighting Intervention on Sleep Quality, Rest-Activity, Mood, and Behavior in Older Adults With Alzheimer Disease and Related Dementias: A Randomized Clinical Trial.
Figueiro MG; Plitnick B; Roohan C; Sahin L; Kalsher M; Rea MS
J Clin Sleep Med; 2019 Dec; 15(12):1757-1767. PubMed ID: 31855161
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
[TBL] [Abstract][Full Text] [Related]
13. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease.
Dowling GA; Burr RL; Van Someren EJ; Hubbard EM; Luxenberg JS; Mastick J; Cooper BA
J Am Geriatr Soc; 2008 Feb; 56(2):239-46. PubMed ID: 18070004
[TBL] [Abstract][Full Text] [Related]
14. Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM-CP): a study protocol.
Adam R; Kanakarajan S; Onyeakazi U; Columb M; Galley H
BMJ Open; 2020 Mar; 10(3):e034443. PubMed ID: 32184313
[TBL] [Abstract][Full Text] [Related]
15. Prolonged-release melatonin in Parkinson's disease patients with a poor sleep quality: A randomized trial.
Ahn JH; Kim M; Park S; Jang W; Park J; Oh E; Cho JW; Kim JS; Youn J
Parkinsonism Relat Disord; 2020 Jun; 75():50-54. PubMed ID: 32480307
[TBL] [Abstract][Full Text] [Related]
16. Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial.
Chang YS; Lin MH; Lee JH; Lee PL; Dai YS; Chu KH; Sun C; Lin YT; Wang LC; Yu HH; Yang YH; Chen CA; Wan KS; Chiang BL
JAMA Pediatr; 2016 Jan; 170(1):35-42. PubMed ID: 26569624
[TBL] [Abstract][Full Text] [Related]
17. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent.
Wyatt JK; Dijk DJ; Ritz-de Cecco A; Ronda JM; Czeisler CA
Sleep; 2006 May; 29(5):609-18. PubMed ID: 16774150
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical Trial.
Moline M; Thein S; Bsharat M; Rabbee N; Kemethofer-Waliczky M; Filippov G; Kubota N; Dhadda S
J Prev Alzheimers Dis; 2021; 8(1):7-18. PubMed ID: 33336219
[TBL] [Abstract][Full Text] [Related]
19. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
[TBL] [Abstract][Full Text] [Related]
20. Endogenous melatonin predicts efficacy of exogenous melatonin in consolidation of fragmented wrist-activity rhythm of adult patients with developmental brain disorders: a double-blind, placebo-controlled, crossover study.
Laakso ML; Lindblom N; Leinonen L; Kaski M
Sleep Med; 2007 Apr; 8(3):222-39. PubMed ID: 17368097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
